MENU
ALXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alexion Pharmaceuticals (ALXN) Ownership - Who owns Alexion Pharmaceuticals?

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Miscellaneous
Capitalization
40.34B
P/E Ratio
59.70
Total Cash
3.51B
Projected Growth
0.02
Total Debt
2.7B
Revenue
6.28B
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
15.87
Total Debt/Equity
4.88
Revenue/Share
28.21 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biologic therapeutic products

Industry NotClassified

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Who owns Alexion Pharmaceuticals? ALXN symbol Ownership - Tickeron.com